Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA.

Neurol Genet. 2019 Jul 9;5(4):e348. doi: 10.1212/NXG.0000000000000348. eCollection 2019 Aug.

2.

Missense mutations in DYT-TOR1A dystonia.

Iqbal Z, Koht J, Pihlstrøm L, Henriksen SP, Cappelletti C, Russel MB, Norberto de Souza O, Skogseid IM, Toft M.

Neurol Genet. 2019 Jun 6;5(4):e343. doi: 10.1212/NXG.0000000000000343. eCollection 2019 Aug. No abstract available.

3.

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

Rongve A, Witoelar A, Ruiz A, Athanasiu L, Abdelnour C, Clarimon J, Heilmann-Heimbach S, Hernández I, Moreno-Grau S, de Rojas I, Morenas-Rodríguez E, Fladby T, Sando SB, Bråthen G, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Londos E, Almdahl IS, Pålhaugen L, Eriksen JA, Djurovic S, Stordal E, Saltvedt I, Ulstein ID, Bettella F, Desikan RS, Idland AV, Toft M, Pihlstrøm L, Snaedal J, Tárraga L, Boada M, Lleó A, Stefánsson H, Stefánsson K, Ramírez A, Aarsland D, Andreassen OA.

Sci Rep. 2019 May 7;9(1):7013. doi: 10.1038/s41598-019-43458-2.

4.

Essential tremor.

Flengsrud K, Toft M, Dietrichs E.

Tidsskr Nor Laegeforen. 2019 Apr 24;139(8). doi: 10.4045/tidsskr.18.0904. Print 2019 May 7. Norwegian.

5.

Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J; 23andMe Research Team, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2019 Jun;34(6):866-875. doi: 10.1002/mds.27659. Epub 2019 Apr 7.

PMID:
30957308
6.

TMEM230 variants in Parkinson's disease.

Iqbal Z, Toft M.

Nat Genet. 2019 Mar;51(3):366. doi: 10.1038/s41588-019-0353-7. No abstract available.

PMID:
30804555
7.

A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease.

Kristiansen M, Maple-Grødem J, Alves G, Arepalli S, Hernandez DG, Iwaki H, Nalls MA, Singleton A, Tysnes OB, Toft M, Pihlstrøm L.

Mov Disord. 2019 Feb;34(2):298-299. doi: 10.1002/mds.27555. Epub 2018 Nov 28. No abstract available.

PMID:
30484896
8.

No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.

Berge-Seidl V, Pihlstrøm L, Wszolek ZK, Ross OA, Toft M.

Neurobiol Aging. 2019 Feb;74:236.e1-236.e5. doi: 10.1016/j.neurobiolaging.2018.09.022. Epub 2018 Sep 22.

PMID:
30340792
9.

A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.

Pihlstrøm L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR; International Parkinson Disease Genomics Consortium; North American Brain Expression Consortium, Singleton AB, Nalls MA, Toft M.

Ann Neurol. 2018 Jul;84(1):117-129. doi: 10.1002/ana.25274. Epub 2018 Aug 26.

PMID:
30146727
10.

Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease.

Blauwendraat C, Reed X, Kia DA, Gan-Or Z, Lesage S, Pihlstrøm L, Guerreiro R, Gibbs JR, Sabir M, Ahmed S, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Hernandez DG, Chung SJ, Goldwurm S, Toft M, Schulte C, Bras J, Wood NW, Brice A, Morris HR, Scholz SW, Nalls MA, Singleton AB, Cookson MR; COURAGE-PD (Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease) Consortium, the French Parkinson’s Disease Consortium, and the International Parkinson’s Disease Genomics Consortium (IPDGC).

JAMA Neurol. 2018 Nov 1;75(11):1416-1422. doi: 10.1001/jamaneurol.2018.1885.

11.

Multiple Microelectrode Recordings in STN-DBS Surgery for Parkinson's Disease: A Randomized Study.

Bjerknes S, Toft M, Konglund AE, Pham U, Waage TR, Pedersen L, Skjelland M, Haraldsen I, Andersson S, Dietrichs E, Skogseid IM.

Mov Disord Clin Pract. 2018 May 8;5(3):296-305. doi: 10.1002/mdc3.12621. eCollection 2018 May-Jun.

12.

Mobility closure in the upper class: assessing time and forms of capital.

Toft M.

Br J Sociol. 2019 Jan;70(1):109-137. doi: 10.1111/1468-4446.12362. Epub 2018 Mar 30.

PMID:
29603121
13.

Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.

Bjørnarå KA, Pihlstrøm L, Dietrichs E, Toft M.

BMC Neurol. 2018 Feb 21;18(1):20. doi: 10.1186/s12883-018-1023-6.

14.

Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease.

Blauwendraat C, Kia DA, Pihlstrøm L, Gan-Or Z, Lesage S, Gibbs JR, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Chung SJ, Goldwurm S, Toft M, Schulte C; International Parkinson's Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Hernandez D, Singleton AB, Nalls MA, Brice A, Scholz SW, Wood NW.

Neurobiol Aging. 2018 Apr;64:159.e5-159.e8. doi: 10.1016/j.neurobiolaging.2017.12.012. Epub 2017 Dec 20.

15.

Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia.

Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CME, Toft M.

PLoS One. 2017 Oct 12;12(10):e0186571. doi: 10.1371/journal.pone.0186571. eCollection 2017.

16.

The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.

Berge-Seidl V, Pihlstrøm L, Maple-Grødem J, Forsgren L, Linder J, Larsen JP, Tysnes OB, Toft M.

Neurosci Lett. 2017 Sep 29;658:48-52. doi: 10.1016/j.neulet.2017.08.040. Epub 2017 Aug 19.

PMID:
28830825
17.

Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia.

Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M.

PLoS One. 2017 Mar 31;12(3):e0174667. doi: 10.1371/journal.pone.0174667. eCollection 2017. Erratum in: PLoS One. 2017 Oct 12;12 (10 ):e0186571.

18.

Microbiota composition of simultaneously colonized mice housed under either a gnotobiotic isolator or individually ventilated cage regime.

Lundberg R, Bahl MI, Licht TR, Toft MF, Hansen AK.

Sci Rep. 2017 Feb 7;7:42245. doi: 10.1038/srep42245.

19.

The mediation effect of emotional eating between depression and body mass index in the two European countries Denmark and Spain.

van Strien T, Winkens L, Toft MB, Pedersen S, Brouwer I, Visser M, Lähteenmäki L.

Appetite. 2016 Oct 1;105:500-8. doi: 10.1016/j.appet.2016.06.025. Epub 2016 Jun 18.

PMID:
27329926
20.

Rare variants in dementia genes and Parkinson's disease.

Iqbal Z, Pihlstrøm L, Rengmark A, Henriksen SP, Linder J, Forsgren L, Toft M.

Eur J Hum Genet. 2016 Dec;24(12):1661-1662. doi: 10.1038/ejhg.2016.79. Epub 2016 Jun 22. No abstract available.

21.

Low frequency of GCH1 and TH mutations in Parkinson's disease.

Rengmark A, Pihlstrøm L, Linder J, Forsgren L, Toft M.

Parkinsonism Relat Disord. 2016 Aug;29:109-11. doi: 10.1016/j.parkreldis.2016.05.010. Epub 2016 May 7.

PMID:
27185167
22.

[Pressure pneumothorax despite oscillating pleural drainage].

Toft MH, Tvede MF.

Ugeskr Laeger. 2016 Mar 14;178(11):V67055. Danish. No abstract available.

PMID:
27032307
23.

Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative.

Baillet A, Gossec L, Carmona L, Wit Md, van Eijk-Hustings Y, Bertheussen H, Alison K, Toft M, Kouloumas M, Ferreira RJ, Oliver S, Rubbert-Roth A, van Assen S, Dixon WG, Finckh A, Zink A, Kremer J, Kvien TK, Nurmohamed M, van der Heijde D, Dougados M.

Ann Rheum Dis. 2016 Jun;75(6):965-73. doi: 10.1136/annrheumdis-2016-209233. Epub 2016 Mar 16. Review.

24.

A cumulative genetic risk score predicts progression in Parkinson's disease.

Pihlstrøm L, Morset KR, Grimstad E, Vitelli V, Toft M.

Mov Disord. 2016 Apr;31(4):487-90. doi: 10.1002/mds.26505. Epub 2016 Feb 8. Review.

PMID:
26853697
25.

Antibiotic-treated versus germ-free rodents for microbiota transplantation studies.

Lundberg R, Toft MF, August B, Hansen AK, Hansen CH.

Gut Microbes. 2016;7(1):68-74. doi: 10.1080/19490976.2015.1127463.

26.

Exome Variant Mining in Familial Parkinson Disease: Will Replication Find the Gold?

Toft M, Ross OA.

JAMA Neurol. 2016 Jan;73(1):21-2. doi: 10.1001/jamaneurol.2015.3536. No abstract available.

PMID:
26595415
27.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

28.

Cumulative genetic risk and age at onset in Parkinson's disease.

Pihlstrøm L, Toft M.

Mov Disord. 2015 Oct;30(12):1712-3. doi: 10.1002/mds.26366. Epub 2015 Aug 3. No abstract available.

PMID:
26234887
29.

Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation.

Pham UH, Andersson S, Toft M, Pripp AH, Konglund AE, Dietrichs E, Malt UF, Skogseid IM, Haraldsen IR, Solbakk AK.

Parkinsons Dis. 2015;2015:461453. doi: 10.1155/2015/461453. Epub 2015 Jun 18.

30.

CHCHD2 and Parkinson's disease.

Iqbal Z, Toft M.

Lancet Neurol. 2015 Jul;14(7):680-1. doi: 10.1016/S1474-4422(15)00096-4. No abstract available.

PMID:
26067113
31.

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CAF, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L.

Alzheimers Dement. 2015 Dec;11(12):1407-1416. doi: 10.1016/j.jalz.2014.12.009. Epub 2015 Apr 30.

32.

Longitudinal assessment of probable rapid eye movement sleep behaviour disorder in Parkinson's disease.

Bjørnarå KA, Dietrichs E, Toft M.

Eur J Neurol. 2015 Aug;22(8):1242-4. doi: 10.1111/ene.12723. Epub 2015 Apr 22.

PMID:
25904103
33.

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.

Pihlstrøm L, Rengmark A, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Dietrichs E, Toft M.

J Hum Genet. 2015 Jul;60(7):357-62. doi: 10.1038/jhg.2015.34. Epub 2015 Apr 9.

PMID:
25855069
34.

Personality changes after deep brain stimulation in Parkinson's disease.

Pham U, Solbakk AK, Skogseid IM, Toft M, Pripp AH, Konglund AE, Andersson S, Haraldsen IR, Aarsland D, Dietrichs E, Malt UF.

Parkinsons Dis. 2015;2015:490507. doi: 10.1155/2015/490507. Epub 2015 Jan 29.

35.

Parkinson's disease correlates with promoter methylation in the α-synuclein gene.

Pihlstrøm L, Berge V, Rengmark A, Toft M.

Mov Disord. 2015 Apr;30(4):577-80. doi: 10.1002/mds.26073. Epub 2014 Dec 27.

PMID:
25545759
36.

Surgical site infections after deep brain stimulation surgery: frequency, characteristics and management in a 10-year period.

Bjerknes S, Skogseid IM, Sæhle T, Dietrichs E, Toft M.

PLoS One. 2014 Aug 14;9(8):e105288. doi: 10.1371/journal.pone.0105288. eCollection 2014.

37.

The microbiota regulates susceptibility to Fas-mediated acute hepatic injury.

Celaj S, Gleeson MW, Deng J, O'Toole GA, Hampton TH, Toft MF, Morrison HG, Sogin ML, Putra J, Suriawinata AA, Gorham JD.

Lab Invest. 2014 Sep;94(9):938-49. doi: 10.1038/labinvest.2014.93. Epub 2014 Jul 28.

38.

Clinical features associated with sleep disturbances in Parkinson's disease.

Bjørnarå KA, Dietrichs E, Toft M.

Clin Neurol Neurosurg. 2014 Sep;124:37-43. doi: 10.1016/j.clineuro.2014.06.027. Epub 2014 Jun 27.

PMID:
25016237
39.

Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortality.

Børretzen MN, Bjerknes S, Sæhle T, Skjelland M, Skogseid IM, Toft M, Dietrichs E.

BMC Neurol. 2014 Jun 5;14:120. doi: 10.1186/1471-2377-14-120.

40.

Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease.

Pihlstrøm L, Rengmark A, Bjørnarå KA, Toft M.

Ann Hum Genet. 2014 May;78(3):243-52. doi: 10.1111/ahg.12060. Epub 2014 Mar 24.

41.

Advances in genetic diagnosis of neurological disorders.

Toft M.

Acta Neurol Scand Suppl. 2014;(198):20-5. doi: 10.1111/ane.12232. Review.

PMID:
24588502
42.

Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene.

Koht J, Rengmark A, Opladen T, Bjørnarå KA, Selberg T, Tallaksen CM, Blau N, Toft M.

Acta Neurol Scand Suppl. 2014;(198):7-12. doi: 10.1111/ane.12230.

PMID:
24588500
43.

Progression and survival in Parkinson's disease with subthalamic nucleus stimulation.

Lilleeng B, Brønnick K, Toft M, Dietrichs E, Larsen JP.

Acta Neurol Scand. 2014 Nov;130(5):292-8. doi: 10.1111/ane.12224. Epub 2014 Feb 4.

PMID:
24495107
44.

Found in transcription: accurate Parkinson's disease classification in peripheral blood.

Karlsson MK, Sharma P, Aasly J, Toft M, Skogar O, Sæbø S, Lönneborg A.

J Parkinsons Dis. 2013;3(1):19-29. doi: 10.3233/JPD-120159.

PMID:
23938308
45.

Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.

Toft M, Dietrichs E.

Mov Disord. 2014 Feb;29(2):275-6. doi: 10.1002/mds.25504. Epub 2013 May 21. No abstract available.

PMID:
23696136
46.

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.

Pihlstrøm L, Axelsson G, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E, Toft M.

Neurobiol Aging. 2013 Jun;34(6):1708.e7-13. doi: 10.1016/j.neurobiolaging.2012.10.019. Epub 2012 Nov 13.

PMID:
23153929
47.

REM sleep behavior disorder in Parkinson's disease--is there a gender difference?

Bjørnarå KA, Dietrichs E, Toft M.

Parkinsonism Relat Disord. 2013 Jan;19(1):120-2. doi: 10.1016/j.parkreldis.2012.05.027. Epub 2012 Jun 20.

PMID:
22726815
48.

Biomass conversion determined via fluorescent cellulose decay assay.

Wischmann B, Toft M, Malten M, McFarland KC.

Methods Enzymol. 2012;510:19-36. doi: 10.1016/B978-0-12-415931-0.00002-1.

PMID:
22608719
49.

An Electronic Patch for wearable health monitoring by reflectance pulse oximetry.

Haahr RG, Duun SB, Toft MH, Belhage B, Larsen J, Birkelund K, Thomsen EV.

IEEE Trans Biomed Circuits Syst. 2012 Feb;6(1):45-53. doi: 10.1109/TBCAS.2011.2164247.

PMID:
23852744
50.

B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.

Ni M, MacFarlane AW 4th, Toft M, Lowell CA, Campbell KS, Hamerman JA.

Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):267-72. doi: 10.1073/pnas.1111957108. Epub 2011 Dec 20.

Supplemental Content

Support Center